REFERENCES
- Delay J., Deniker P. Drug-Induced Extrapyramidal Syndromes. Handbook of Clinical Neurology, P.J. Viken, G.W. Bruyn, AmsterdamNorth Holland 1968; Vol 6: 248–266
- Taniguchi N., Tanii H., Nishikawa T., Miyamae Y., Shinozaki K., Inoue Y., Morihara T., Nakano Y., Nishimura T., Takeda M. Classification System of Complications in Neuroleptic Malignant Syndrome. Meth. Find. Exp. Clin. Pharmacol. 1997; 19: 193–199
- Shalev A., Munitz H. The Neuroleptic Malignant Syndrome: Agent and Host Interaction. Acta. Psychiatr. Scand. 1986; 73: 337–347
- Perez-Vela J.L., Casado M.S., Riera A.S.I., Checa A.A., Cubedo R.C., Lopez E.A. Neuroleptic Malignant Syndrome in a Patient with Head Injury. Intens. Care Med. 1996; 22: 593–595
- Kellam A.M.P. The Neuroleptic Malignant Syndrome, So-called: A Survey of the World Literature. Br. J. Psychiat. 1987; 150: 751–759
- Shalev A., Hermesh H., Munitz H. Mortality From Neuroleptic Malignant Syndrome. J. Clin. Psychiat. 1989; 50: 18–25
- Teo S.K., Sin Fai Lam K.N., Chew W.L.S. A Fulminant Case of Neuroleptic Malignant Syndrome. Singapore Med. J. 1994; 35: 110–111